Anti-nerve growth factor antibodies may relieve osteoarthritis pain and improve function

Anti-nerve growth factor antibodies, anti-NGF antibodies, tanuzemab, fasinumab, arthritis drug, arthritis pain, arthritis digestBlocking nerve growth factor (NGF) with antibodies is a promising strategy for treatment of chronic pain associated with osteoarthritis (OA). Studies have looked at if anti-NGF antibodies can work on osteoarthritis pain and chronic low-back pain, and a group of researchers decided to analyse them to see what trends emerged, reporting their findings in Current Rheumatology Reports. Continue reading